Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
294.06
5.88 (2.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
2.04%
-1.44%
1W
4.01%
-1.94%
1M
-1.14%
-1.45%
YTD
-26.05%
7.6%
1Y
-9.52%
22.24%
3Y
52.61%
69.39%
5Y
69.31%
73.64%
10Y
441.45%
248.53%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.54%
0%
-4.54%
6 Months
-26.61%
0%
-26.61%
1 Year
-9.52%
0%
-9.52%
2 Years
31.92%
0%
31.92%
3 Years
52.61%
0%
52.61%
4 Years
99.36%
0%
99.36%
5 Years
69.31%
0%
69.31%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary